International Journal of Hematology

DOI: 10.1007/s12185-012-1250-3 Pages: 299-300

Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data

1. Centre Hospitalier Universitaire Vaudois and University of Lausanne, Division of Clinical Pharmacology, Biomedicine, Department of Laboratories

2. Hematology

3. Clinique La Prairie

4. Centre Hospitalier Universitaire Vaudois, Division of Clinical Pharmacology, Biomedicine, Department of Laboratories

Correspondence to:
Françoise Livio
Tel: +41-21-3144268
Fax: +41-21-3144266
Email: francoise.livio@chuv.ch

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

Share the Knowledge